title: Advances in the treatment of persistent pulmonary hypertension of the newborn.
abstract: Despite an association with meconium and blood aspiration, pneumonia, sepsis, pneumothorax, prematurity, and congenital diaphragmatic hernia, no cause for persistent pulmonary hypertension of the newborn can be found in many cases. This article discusses the advances in current therapies including the promising new therapy of inhaled nitric oxide.
authors.affiliation: Department of Anesthesia, Harvard Medical School, Boston, Massachusetts.
authors.forename: J D
authors.initials: JD
authors.lastname: Roberts
authors.forename: P W
authors.initials: PW
authors.lastname: Shaul
mesh_terms: D000818:Animals; D015199:Extracorporeal Membrane Oxygenation; D006612:High-Frequency Ventilation; D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000627:therapeutic use; D010547:Persistent Fetal Circulation Syndrome / Q000628:therapy*; D011652:Pulmonary Circulation / Q000187:drug effects; D012121:Respiration, Artificial; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D014665:Vasodilator Agents; D009569:Nitric Oxide